Michael Dupont

Accomplished Vice President of New Business Development (M&A, Divestments, Strategic Alliances), Corporate Strategy, & Global Marketing with more than 21 years of Medical Device, Life Science, and Bio-Pharmaceutical experience. Extensive track record of success in a variety of senior management, global marketing (upstream & downstream), product management, business development, strategy, and sales positions. Recognized for effectively leading teams and developing people, creating and executing strategic business plans, developing and executing successful new product launch campaigns, identifying, assessing, and executing new business development opportunities including acquisition, divestments, licensing, and distribution opportunities. Michael is currently the Vice President of NBD (M&A, Divestments, Partnerships) within Getinge Group’s Acute Care Therapies business area. His past companies include Atrium Medical Corporation, Pfizer, and Waters Corporation. Michael received his science degree with distinction from Worcester Polytechnic Institute and continues his educational learnings through various programs at Harvard Business School, Wharton Business School, and Copenhagen Business School.